500 related articles for article (PubMed ID: 20066963)
1. Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.
Wu GZ; Hong G; Zhang WP; Zhang HB
Arzneimittelforschung; 2009; 59(11):550-6. PubMed ID: 20066963
[TBL] [Abstract][Full Text] [Related]
2. I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle.
Lu N; Zhan M; Gao C; Wu G; Zhang H
Thromb Res; 2012 Oct; 130(4):e209-15. PubMed ID: 22909828
[TBL] [Abstract][Full Text] [Related]
3. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
4. A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat.
Ohyama S; Takano H; Iino T; Nishimura T; Zhou YP; Langdon RB; Zhang BB; Eiki J
Eur J Pharmacol; 2010 Aug; 640(1-3):250-6. PubMed ID: 20465996
[TBL] [Abstract][Full Text] [Related]
5. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus.
Park K; Lee BM; Hyun KH; Lee DH; Choi HH; Kim H; Chong W; Kim KB; Nam SY
Bioorg Med Chem; 2014 Apr; 22(7):2280-93. PubMed ID: 24588963
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs.
Eiki J; Nagata Y; Futamura M; Sasaki-Yamamoto K; Iino T; Nishimura T; Chiba M; Ohyama S; Yoshida-Yoshimioto R; Fujii K; Hosaka H; Goto-Shimazaki H; Kadotani A; Ohe T; Lin S; Langdon RB; Berger JP
Mol Pharmacol; 2011 Dec; 80(6):1156-65. PubMed ID: 21937665
[TBL] [Abstract][Full Text] [Related]
8. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
[TBL] [Abstract][Full Text] [Related]
9. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
11. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
[TBL] [Abstract][Full Text] [Related]
13. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
14. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
[TBL] [Abstract][Full Text] [Related]
15. Anti-diabetic effect of methylswertianin and bellidifolin from Swertia punicea Hemsl. and its potential mechanism.
Tian LY; Bai X; Chen XH; Fang JB; Liu SH; Chen JC
Phytomedicine; 2010 Jun; 17(7):533-9. PubMed ID: 19962285
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetic effect of Symplocos cochinchinensis (Lour.) S. Moore. in type 2 diabetic rats.
Sunil C; Ignacimuthu S; Agastian P
J Ethnopharmacol; 2011 Mar; 134(2):298-304. PubMed ID: 21182925
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic effect of a novel dialysed fenugreek seeds extract is sustainable and is mediated, in part, by the activation of hepatic enzymes.
Vijayakumar MV; Bhat MK
Phytother Res; 2008 Apr; 22(4):500-5. PubMed ID: 18338783
[TBL] [Abstract][Full Text] [Related]
18. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.
Müller G; Korndörfer A; Kornak U; Malaisse WJ
Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components.
Beppu H; Shimpo K; Chihara T; Kaneko T; Tamai I; Yamaji S; Ozaki S; Kuzuya H; Sonoda S
J Ethnopharmacol; 2006 Feb; 103(3):468-77. PubMed ID: 16406411
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
